Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
FLASH: BSX COO to step down by end of year | Personnel Moves
Boston Scientific Corp. (NYSE:BSX) COO Samuel Leno announced his retirement as executive VP and chief operating officer after three years with med-tech giant.
Leno made the announcement internally on Friday, Oct. 28, according to documents filed with the SEC.
Leno joined Boston Scientific in June 2007 as executive VP of finance and information systems and CFO. In March 2010, he was appointed executive VP and COO.
CaridianBCT and Terumo unite to become Terumo BCT
CaridianBCT and Terumo Transfusion unveiled plans to join the two companies into Terumo BCT at this year’s American Assn. of Blood Banks meeting.
The two companies will operate independently until spring 2012 when they will combine to form blood component technology company Terumo BCT.
